Until now, it was known that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi which causes borreliosis and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists from the University of Zurich confirm the existence of another tick disease in Switzerland neoehrlichiosis.
The pathogenic bacteria Candidatus Neoehrlichia mikurensis was first discovered in ticks and rodents in Europe and Asia in 1999. In 2010, Guido Bloemberg, head of molecular diagnostics at the Institute of Medical Microbiology, and colleagues from Sweden and Germany, diagnosed the world's first infections in humans and dubbed the disease "neoehrlichiosis," by detection of the bacterium in the patients' blood. Two more cases were identified at the University of Zurich's Institute of Medical Microbiology in October 2011 and January 2012. So far, a total of eight patients have been described in Europe, three of whom come from the Zurich area. They suffered from relapsing fevers of up to 40 degrees, weight loss and general malaise.
Bloemberg's team studied around 2,000 ticks from the neighborhood of the three Swiss patients, who often spent time in forests and fields. The result: A large number of ticks in the Zurich area  5 percent to 10 percent carry Candidatus Neoehrlichia mikurensis.
"Our study shows that the greater Zurich region is a risk area for neoehrlichiosis, especially for immunocompromised people," explains Florian Maurer from the University of Zurich's Institute of Medical Microbiology.
Almost all the patients in Europe to date have had a weakened immune system. However, people with a healthy immune system recently contracted neoehrlichiosis from a tick bite in China, too.
"Because the bacteria that cause neoehrlichiosis couldn't be bred in the lab until now and thus no rapid tests were available, many infections might have remained undetected," says Bloemberg.
However, help is now at hand with the new DNA test the researchers have developed: It can detect an infection definitively within one working day and also be used for larger test series.
The Swiss patients could be cured fully with a course of antibiotics. Within only a few weeks of beginning the treatment, the microorganism responsible could no longer be detected in their blood.
"How well the bacterium is transmitted to humans via a bite from an infected tick, however, still needs to be researched," Bloemberg adds.
Reference: Maurer F, Keller P, et al.  Close geographic association of human neoehrlichiosis and tick populations carrying Candidatus Neoehrlichia mikurensis in Eastern Switzerland. Journal of Clinical Microbiology, 31 October, 2012. DOI: 10.1128/JCM.01955-12
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.